RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 56 - per page Next page
Order by
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
BIOMEDICA FOSCAMA's leading drug Esafosfina® has been acknowledged as a safe and effective phosphorus source in total parenteral nutrition More
New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004. More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
GlaxoSmithKline obtains exclusive rights for an innovative topical patch to treat cold sores More
tesa AG, based in Hamburg, has acquired Labtec Gesellschaft für technologische Forschung und Entwicklung mbH More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
A dozen University of Western Ontario research projects, including ensuring innovative research on Metabolic Syndrome and personalized medicine, have received $19-million from the Ontario Research Fund. More
Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade More
Questcor Pharmaceuticals has signed an agreement with Beacon Pharmaceuticals of Tunbridge Wells, Kent, UK, for the exclusive marketing and distribution of H.P. Acthar(R) Gel in the United Kingdom. More
Displaying 1..10 of 56 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us